Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

Clinical trial NCT01012492 · COMPLETED

Trial details

NCT number: NCT01012492
Sponsor: Boston Children's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

AML ALL Undifferentiated Leukemia Biphenotypic Leukemia Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts Refractory Anemia With Excess Blasts-1 (5-10% Blasts)Refractory Anemia With Excess Blasts-2 (10-20% Blasts)Myelodysplastic Syndrome, Unclassified MDS Associated With Isolated Del (5q)

Start date: 2009-11-01
Primary completion: 2012-11-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.